Jeffrey Scott Sherman - Dec 5, 2022 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role: Chief Financial Officer
Signature: /s/ Ali Olivo, Attorney-in-Fact
Stock symbol: NEO
Transactions as of: Dec 5, 2022
Transactions value $: $0
Form type: 4
Date filed: 12/7/2022, 07:47 PM
Previous filing: Jan 7, 2022
Next filing: May 15, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEO	Common Stock	Award	$0	+44.6K		$0.00	44.6K	Dec 5, 2022	Direct	F1
transaction	NEO	Common Stock	Award	$0	+89.2K	+200%	$0.00	134K	Dec 5, 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NEO	Stock Option (Right to Buy)	Award	$0	+249K		$0.00	249K	Dec 5, 2022	Common Stock	249K	$11.62	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On December 5, 2022, Mr. Sherman was granted an award of 44,603 shares of restricted stock. The shares subject to this award shall vest ratably over four years with the first tranche vesting on December 7, 2023.
F2	On December 5, 2022, Mr. Sherman was granted an award of 89,206 shares of restricted stock. The shares subject to this award shall vest upon the achievement of an absolute total stockholder return of at least 20% for the period commencing December 7, 2022 and ending December 6, 2023. If such vesting condition is met, the shares subject to the award shall vest ratably over four years with the first tranche vesting on December 7, 2023.
F3	On December 5, 2022, Mr. Sherman was granted 249,169 stock options. These awards vest ratably over four years with the first tranche vesting on December 7, 2023.